- CA$40.89bn
- CA$48.28bn
- CA$52.20bn
- 88
- 91
- 39
- 84
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 20,181 | 13,227 | 46,357 | 66,897 | 52,204 |
Cost of Revenue | |||||
Gross Profit | 11,753 | 8,108 | 22,876 | 33,096 | 27,489 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 18,533 | 15,803 | 43,219 | 56,012 | 46,649 |
Operating Profit | 1,648 | -2,576 | 3,138 | 10,885 | 5,555 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,397 | -3,230 | 1,315 | 8,731 | 5,040 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,194 | -2,379 | 587 | 6,450 | 4,109 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2,194 | -2,379 | 587 | 6,450 | 4,109 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,194 | -2,379 | 553 | 6,415 | 4,073 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.8 | -1.1 | 0.638 | 3.25 | 2.15 |
Dividends per Share |